JamesWJohnsonJr.MD

PubMed

• 122 citations
  β Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin Resistance.
  Cristina Aguayo-Mazzucato, Mark van Haaren, Magdalena Mruk, Terence B. Lee, Caitlin Crawford, Jennifer Hollister-Lock, James W. Johnson, Aref G. Ebrahimi, Jonathan M. ...> ;Cell Metabolism. 2017 Apr 4
• Reply to Young, Ochi, and Marimuthu
  John C. Williamson, Haley G. Gibbs, Christopher A. Ohl, James W. Johnson, James R. Beardsley, Vera P. Luther, Kristina E. E. Rokas> ;Clinical Infectious Diseases. 2016 Mar 15
• 72 citations
  The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection
  Kristina E. E. Rokas, James W. Johnson, James R. Beardsley, Christopher A. Ohl, Vera P. Luther, John C. Williamson> ;Clinical Infectious Diseases. 2015 May 29
• 19 citations
  Modification of Diet in Renal Disease and Modified Cockcroft-Gault Formulas in Predicting Aminoglycoside Elimination
  P. Brandon Bookstaver, James W. Johnson, Thomas P. McCoy, David W. Stewart, John C. Williamson> ;The Annals of Pharmacotherapy. 2008 Dec 1
• 104 citations
  Using Local Microbiologic Data To Develop Institution-Specific Guidelines for the Treatment of Hospital-Acquired Pneumonia
  James R. Beardsley, John C. Williamson, James W. Johnson, Christopher A. Ohl, Tobi B. Karchmer, David L. Bowton> ;Chest. 2006 Sep 1
• 97 citations
  Ventricular Reverse Remodeling and 6-Month Outcomes in Patients Receiving Cardiac Resynchronization Therapy: Analysis of the MIRACLE Study
  Gregory W. Woo, Susan Petersen-Stejskal, James W. Johnson, Jamie B. Conti, Juan A. Aranda, Anne B. Curtis> ;Journal of Interventional Cardiac Electrophysiology. 2005 Mar 1
• 6 citations
  Effect of aspirin use on death and recurrent myocardial infarction in current and former cigarette smokers
  Laurie L. Fitch, Henry Buchwald, John P. Matts, James W. Johnson, Christian T. Campos, John M. Long> ;American Heart Journal. 1995 Apr 1
• 14 citations
  Perception of quality of life before and after disclosure of trial results: A report from the Program on the Surgical Control of the Hyperlipidemias (POSCH)
  Henry Buchwald, Laurie L. Fitch, John P. Matts, James W. Johnson, Betty J. Hansen, Meridith R. Stuenkel, Helene B. Brooks> ;Controlled Clinical Trials. 1993 Dec 1
• 10 citations
  Plasma lipid concentrations and subsequent coronary occlusion after a first myocardial infarction
  Joe K. Bissett, Richard P. Wyeth, John P. Matts, James W. Johnson> ;The American Journal of the Medical Sciences. 1993 Mar 1
• 64 citations
  Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. POSCH Group.
  John P. Matts, James N. Karnegis, Christian T. Campos, Laurie L. Fitch, James W. Johnson, Henry Buchwald> ;The Journal of Family Practice. 1993 May 1
• 72 citations
  Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis
  Thomas J. Lester, James W. Johnson, Janet Cuttner> ;The American Journal of Medicine. 1985 Jul 1
• 59 citations
  Fecal α1-antitrypsin measurement: An indicator of Crohn's disease activity
  Samuel Meyers, Anita M. Wolke, Steven P. Field, Eric J. Feuer, James W. Johnson, Henry D. Janowitz> ;Gastroenterology. 1985 Jul 1
• 9 citations
  Measurement of Urinary Renin Activity by Radioimmunoassay: Sequential Studies in Acute Renal Failure in Man
  William E. Haley, James W. Johnson> ;Nephron. 1978 Jan 1
• 13 citations
  Metabolic studies of bone in uremia before and after treatment.
  George Nichols, Barry Flanagan, Jaap van der Sluys Veer, James W. Johnson, Constantine L. Hampers, John P. Merrill> ;Metabolism. 1972 Apr 1
• Join now to see all